Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study

BACKGROUND: Glutathione (GSH), a major intracellular antioxidant, plays a role in NMDA receptor-mediated neurotransmission, which is involved in the pathophysiology of schizophrenia. In the present study, we aimed to investigate whether GSH levels are altered in the posterior medial frontal cortex of schizophrenic patients. Furthermore, we examined correlations between GSH levels and clinical variables in patients. METHODS AND FINDINGS: Twenty schizophrenia patients and 16 age- and gender-matched normal controls were enrolled to examine the levels of GSH in the posterior medial frontal cortex by using 3T SIGNA EXCITE (1)H-MRS with the spectral editing technique, MEGA-PRESS. Clinical variables of patients were assessed by the Global Assessment of Functioning (GAF), Scale for the Assessment of Negative Symptoms (SANS), Brief Psychiatric Rating Scale (BPRS), Drug-Induced Extra-Pyramidal Symptoms Scale (DIEPSS), and five cognitive performance tests (Word Fluency Test, Stroop Test, Trail Making Test, Wisconsin Card Sorting Test and Digit Span Distractibility Test). Levels of GSH in the posterior medial frontal cortex of schizophrenic patients were not different from those of normal controls. However, we found a significant negative correlation between GSH levels and the severity of negative symptoms (SANS total score and negative symptom subscore on BPRS) in patients. There were no correlations between brain GSH levels and scores on any cognitive performance test except Trail Making Test part A. CONCLUSION: These results suggest that GSH levels in the posterior medial frontal cortex may be related to negative symptoms in schizophrenic patients. Therefore, agents that increase GSH levels in the brain could be potential therapeutic drugs for negative symptoms in schizophrenia

High genetic homogeneity of the moon jelly Aurelia aurita (Scyphozoa, Semaeostomeae) along the Mediterranean coast of Tunisia

The moon jelly Aurelia aurita is one of the most common and widespread species of scyphomedusa in the Mediterranean Sea. In all, 18 allozyme loci were studied to investigate the genetic variation and population structure of 11 A. aurita populations from the Tunisian coast. Polymorphism was detected at 14 loci across the sampling localities. Gene frequency differences rather than alternative fixation of alleles characterised the collecting sites. The mean number of alleles per locus ranged from 1.89 to 2.17 (average 2.02), and the mean values of observed (Ho) and expected (He) heterozygosities ranged from 0.20 to 0.36 and from 0.32 to 0.37 respectively. Five out of 14 polymorphic loci were out of Hardy-Weinberg equilibrium (H-WE). Likewise, the multilocus tests showed deviation from H-WE in six populations. These populations apparently showed heterozygote deficiency, whereas the average heterozygosity for the  remaining ones is quite similar to the expected values. Despite extensive sampling across a microgeographical scale and genotyping efforts, the populations of A. aurita under study showed an absence of genetic differentiation under the background of high gene flow (mean FST = 0.01, p < 0.05) and higher value of Nem, suggesting that A. aurita is genetically homogeneous throughout the study area. The absence of population genetic structuring may be associated with environmental conditions and life-history parameters. Keywords: allozyme, Aurelia aurita, gene flow, Mediterranean Sea, TunisiaAfrican Journal of Marine Science 2009, 31(1): 73–8

Association of Stromal Cell-Derived Factor-1-3 &apos; A Polymorphism to Higher Mobilization of Hematopoietic Stem Cells CD34+in Tunisian Population

We explored the influence of polymorphisms in genes encoding the chemokine stromal cellderived factor-1 (SDF-1)/CXCL12 in a cohort of Tunisian patients with malignant hematologic diseases multiple myeloma [MM], non-Hodgkin's lymphoma [NHL], Hodgkin's disease, and acute myeloid leukemia [AML], who underwent stem cell mobilization for autologous transplantation versus a group of healthy donors for allogeneic transplantation. Polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLp) analysis was used for rapid identification of genotypes. Significant associations for SDF1-3\ue2\u80\ub2A polymorphism were observed exclusively in patients with MM and NHL. While there was a lack of all association of SDF-1 polymorphism with AML patients. However, considering that the ability of mobilization varies among subjects, we have observed that the SDF1-3\ue2\u80\ub2A allele was associated with good mobilization capacity. Interestingly, the association was mainly observed among healthy allogeneic transplant donors where the analysis was not biased by background disease or chemotherapy (P = .010; odds ratio = 2.603; confidence interval [95%] = 1.2395.466)